New Delhi, March 12 -- A once-a-year prophylactic injection to protect against HIV has proven to be safe in clinical trial and shown promise as a long-acting prevention medication, a finding that may prove beneficial for the high-risk population who at present have to rely on daily pills or alternate-month shots....